Article
CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Dec 2011
Iacobucci Ilaria, Ferrari Anna, Lonetti Annalisa, Papayannidis Cristina, Paoloni Francesca, Trino Stefania, Storlazzi Clelia Tiziana, Ottaviani Emanuela, Cattina Federica, Impera Luciana, Abbenante Maria Chiara, Vignetti Marco, Vitale Antonella, Potenza Leonardo, Paolini Stefania, Soverini Simona, Pane Fabrizio, Luppi Mario, Foà Robin, Baccarani Michele, Martinelli Giovanni
Abstract excerpt
PURPOSE: The 9p21 locus, encoding three important tumor suppressors (p16/CDKN2A, p14/ARF, and p15/CDKN2B), is a major target of inactivation in the pathogenesis of many human tumors. PATIENTS AND METHODS: To explore, at high resolution, the frequency and size of alterations affecting this locus in adult BCR-ABL1-positive acute lymphoblastic leukemia (ALL) and to investigate their prognostic value, 112 patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
